Mitochondrial diseases: Therapeutic approaches

Bioscience Reports

Volumn 27, Issue 1-3, 2007, Pages 125-137

  DiMauro, Salvatore ^a   Mancuso, Michelangelo ^b  

^a Columbia University Medical Center ^*  (United States)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Mitochondrial diseases; mtDNA; Therapy

Indexed keywords

ANTICONVULSIVE AGENT; CARNITINE; CELL NUCLEUS DNA; CHLORAMPHENICOL; FOLIC ACID; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; RIBOFLAVIN; THIAMINE; THYMIDINE KINASE; UBIDECARENONE;

AEROBIC CAPACITY; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIAL; CONFERENCE PAPER; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TOXICITY; EXERCISE; FRIEDREICH ATAXIA; GENE MUTATION; GENETIC COUNSELING; GENOME; GERM LINE GENE THERAPY; HEMODIALYSIS; HETEROPLASMY; HUMAN; HUNTINGTON CHOREA; LUFT DISEASE; MITOCHONDRIAL ENCEPHALOMYOPATHY; PALLIATIVE THERAPY; PARKINSON DISEASE; PHYSIOTHERAPY; PRENATAL DIAGNOSIS; SURGICAL TECHNIQUE;

ANIMALS; CLINICAL TRIALS; DNA, MITOCHONDRIAL; EXERCISE THERAPY; GENE THERAPY; GENETIC COUNSELING; HUMANS; MITOCHONDRIAL DISEASES; TREATMENT OUTCOME;

EID: 34250676955     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10540-007-9041-4     Document Type: Conference Paper

References (64)

1. Allen RJ, DiMauro S, Coulter DL, Papadimitriou A, Rothenberg SP (1983) Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Ann Neurol 13:679-682
2. Andrews RM, Griffiths PG, Chinnery PF, Turnbull DM (1999) Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. Eye 13:769-772
3. Argov Z, Bank WJ, Maris J, Eleff S, Kennaway NG, Olson RE, Chance B (1986) Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study. Ann Neurol 19:598-602
4. Bai Y, Hajek P, Chomyn A, Chan E, Seo BB, Matsuno-Yagi A, Yagi T, Attardi G (2001) Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene. J Biol Chem 276:38808-38813
5. Barritt JA, Brenner CA, Malter HE, Cohen J (2001) Mitochondria in human offspring derived from ooplasmic transplantation. Hum Reprod 16:513-516
6. Bayona-Bafaluy MP, Blits B, Battersby BJ, Shoubridge EA, Moraes CT (2005) Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease. Proc Natl Acad Sci USA 102:14392-14397
7. Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495-505
8. Bernes SM, Bacino C, Prezant TR, Pearson MA, Wood TS, Fournier P, Fischel-Ghodsian N (1993) Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome. J Pediatr 123:598-602
9. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishi A, DiMauro S (1996) Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 46:1329-1334
10. Chinnery PF, Taylor RW, Diekert K, Lill R, Turnbull DM, Lightowlers RN (1999) Peptic nucleic acid delivery to human mitochondria. Gene Therapy 6:1919-1928
11. Chinnery P, Majamaa K, Turnbull D, Thorburn D (2006) Treatment for mitochondrial disorders. Cochrane Database Syst Rev 1:CD004426
12. Clark KM, Bindoff LA, Lightowlers RN, Andrews RM, Griffiths PG, Johnson MA, Brierley EJ, Turnbull DM (1997) Reversal of a mitochondrial DNA defect in human skeletal muscle. Nat Genet 16: 222-224
13. De Vivo DC, DiMauro S (1999) Mitochondrial diseases. In: Swaiman KF, Ashwal S (eds) Pediatric neurology: principles & practice, vol 1. St. Louis, Mosby, pp 494-509
14. Di Giovanni S, Mirabella M, Spinazzola A, Crociani P, Silvestri G, Broccolini A, Tonali P, DiMauro S, Servidei S (2001) Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology 57:515-518
15. DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348:2656-2668
16. DiMauro S, Bonilla E, Lee CP, Schotland DL, Scarpa A, Conn H Jr, Chance B (1976) Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. J Neurol Sci 27:217-232
17. DiMauro S, Hirano M, Kaufmann P, Mann JJ (2006) Mitochondrial psychiatry. In: DiMauro S, Hirano M, Schon EA (eds) Mitochondrial medicine. Informa Healthcare, London, pp 261-277
18. Dubern B, Broue P, Dubuisson C, Cormier-Daire V, Habes D, Chardot C, Devictor D, Munnich A, Bernard O (2001) Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation 71:633-637
19. Eleff S, Kennaway NG, Buist NR, Darley-Usmar VM, Capaldi RA, Bank WJ, Chance B (1984) 31P-NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA 81:3529-3533
20. Ferrante KL, Shefner J, Zhang H, Betensky R, O'Brien M, Yu H, Fantasia M, Taft J, Beal MF, Traynor B, Newhall K, Donofrio P, Caress J, Ashburn C, Freiberg B, O'Neill C, Paladenech C, Walker T, Pestronk A, Abrams B, Florence J, Renna R, Schierbecker J, Malkus B, Cudkowicz M (2005) Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS. Neurology 65:1834-1836
21. Fu K, Hartlen R, Johns T, Genge A, Karpati G, Shoubridge EA (1996) A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy. Hum Mol Genet 5:1835-1840
22. Guy J, Qi X, Pallotti F, Schon EA, Manfredi G, Carelli V, Martinuzzi A, Hauswirth WW, Lewin AS (2002) Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy. Ann Neurol 52:534-542
23. Haydar NA, Conn HL Jr, Afifi A, Wakid N, Ballas S, Fawaz K (1971) Severe hypermetabolism with primary abnormality of skeletal muscle mitochondria. Ann Intern Med 74:548-558
24. Jaksch M, Paret C, Stucka R, Horn N, Muller-Hocker J, Horvath R, Trepesch N, Stecker G, Freisinger P, Thirion C, Muller J, Lunkwitz R, Rodel G, Shoubridge EA, Lochmuller H (2001) Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts. Hum Mol Genet 10:3025-3035
25. Karadimas CL, Greenstein P, Sue CM, Joseph JT, Tanji K, Haller RG, Taivassalo T, Davidson MM, Shanske S, Bonilla E, DiMauro S (2000) Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mtDNA. Neurology 55:644-649
26. Kaufmann P, Shungu DC, Sano MC, Jhung S, Engelstad K, Mitsis E, Mao X, Shanske S, Hirano M, DiMauro S, De Vivo DC (2004) Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 62:1297-1302
27. Kaufmann P, Engelstad K, Wei Y, Jhung S, Sano MC, Shungu DC, Millar WS, Hong X, Gooch CL, Mao X, Pascual JM, Hirano M, Stacpoole PW, DiMauro S, De Vivo DC (2006) Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 66:324-330
28. Keightley JA, Anitori R, Burton MD, Quan F, Buist NR, Kennaway NG (2000) Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene. Am J Hum Genet 67:1400-1410
29. Kennaway NG, Buist NR, Darley-Usmar VM, Papadimitriou A, Dimauro S, Kelley RI, Capaldi RA, Blank NK, D'Agostino A (1984) Lactic acidosis and mitochondrial myopathy associated with deficiency of several components of complex III of the respiratory chain. Pediatr Res 18:991-999
30. Kolesnikova OA, Entelis NS, Mireau H, Fox TD, Martin RP, Tarassov IA (2000) Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm. Science 289:1931-1933
31. Kolesnikova OA, Entelis NS, Jacquin-Becker C, Goltzene F, Chrzanowska-Lightowlers ZM, Lightowlers RN, Martin RP, Tarassov I (2004) Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells. Hum Mol Genet 13:2519-2534
32. Mancuso M, Coppede F, Migliore L, Siciliano G, Murri L (2006) Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimers Dis 10:59-73
33. Manfredi G, Fu J, Ojaimi J, Sadlock JE, Kwong JQ, Guy J, Schon EA (2002) Rescue of an ATP synthesis deficiency in mtDNA-mutant human cells by transfer of MTATP6, a mtDNA-encoded gene, to the nucleus. Nat Genet 30:394-399
34. Manfredi G, Gupta N, Vazquez-Memije ME, Sadlock JE, Spinazzola A, De Vivo DC, Schon EA (1999) Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene. J Biol Chem 274:9386-9391
35. Matsuoka T, Maeda H, Goto Y, Nonaka I (1992) Muscle coenzyme Q10 in mitochondrial encephalomyopathies. Neuromuscul Disord 1:443-447
36. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M, Tsuji A (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94
37. Nishino I, Spinazzola A, Papadimitriou A, Hammans S, Steiner I, Hahn CD, Connolly AM, Verloes A, Guimaraes J, Maillard I, Hamano H, Donati MA, Semrad CE, Russell JA, Andreu AL, Hadjigeorgiou GM, Vu TH, Tadesse S, Nygaard TG, Nonaka I, Hirano I, Bonilla E, Rowland LP, DiMauro S, Hirano M (2000) Ann Neurol 47:792-800
38. Ojaimi J, Pan J, Santra S, Snell WJ, Schon EA (2002) An algal nucleus-encoded subunit of mitochondrial ATP synthase rescues a defect in the analogous human mitochondrial-encoded subunit. Mol Biol Cell 13:3836-3844
39. Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE, Krishna S, Walker W, Selby J, Glerum DM, Coster RV, Lyon G, Scalais E, Lebel R, Kaplan P, Shanske S, De Vivo DC, Bonilla E, Hirano M, DiMauro S, Schon EA (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23:333-337
40. Puoti G, Carrara F, Sampaolo S, De Caro M, Vincitorio CM, Invernizzi F, Zeviani M (2003) Identical large-scale rearrangement of mitochondrial DNA causes Kearns-Sayre syndrome in a mother and son. Am J Med Genet 40:858-863
41. Qi X, Lewin AS, Hauswirth WW, Guy J (2003) Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Invest Ophthalmol Vis Sci 44:1088-1096
42. Qi X, Lewin AS, Hauswirth WW, Guy J (2003) Suppression of complex I gene expression induces optic neuropathy. Ann Neurol 53:198-205
43. Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J (2004) SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I. Ann Neurol 56:182-191
44. Quinzii CM, Dimauro S, Hirano M (2007) Human coenzyme Q(10) deficiency. Neurochem Res 32:723-727
45. Salviati L, Hernandez-Rosa E, Walker WF, Sacconi S, DiMauro S, Schon EA, Davidson MM (2002a) Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations. Biochem J 363:321-327
46. Salviati L, Sacconi S, Mancuso M, Otaegui D, Camano P, Marina A, Rabinowitz S, Shiffman R, Thompson K, Wilson CM, Feigenbaum A, Naini AB, Hirano M, Bonilla E, DiMauro S, Vu TH (2002b) Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol 52:311-317
47. Santorelli FM, Gagliardi MG, Dionisi-Vici C, Parisi F, Tessa A, Carrozzo R, Piemonte F, Pfeiffer K, Schagger H, Bertini E (2002) Hypertrophic cardiomyopathy and mtDNA depletion. Successful treatment with heart transplantation. Neuromusc Disord 12:56-59
48. Santra S, Gilkerson RW, Davidson MM, Schon EA (2004) Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells. Ann Neurol 56:662-669
49. Seo BB, Kitajima-Ihara T, Chan EK, Scheffler IE, Matsuno-Yagi A, Yagi T (1998) Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc Natl Acad Sci USA 95:9167-9171
50. Shanske S, Tang Y, Hirano M, Nishigaki Y, Tanji K, Bonilla E, Sue C, Krishna S, Carlo JR, Willner J, Schon EA, DiMauro S (2002) Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with Pearson syndrome. Am J Hum Genet 71:679-683
51. Shoubridge EA, Johns T, Karpati G (1997) Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibers in a patient with a tRNA point mutation and mitochondrial encephalomyopathy. Hum Mol Genet 6:2239-2242
52. Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M, Lew M, Parkinson Study Group (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59:1541-1550
53. Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S, Pela I, Zammarchi E, Donati MA, Oliver JA, Hirano M (2002) Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277:4128-4132
54. Stacpoole PW (1989) The pharmacology of dichloroacetate. Metabolism 38:1124-1144
55. Sue CM, Lipsett LJ, Crimmins DS, Tsang CS, Boyages SC, Presgrave CM, Gibson WP, Byrne E, Morris JG (1998) Cochlear origin of hearing loss in MELAS syndrome. Ann Neurol 43:350-359
56. Taanman JW, Muddle JR, Muntau AC (2003) Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase-deficient fibroblasts. Hum Mol Genet 12:1839-1845
57. Taivassalo T, Haller RG (2004) Implications of exercise training in mtDNA defects-use or lose it? Biochim Biophys Acta 1659:221-231
58. Taivassalo T, Haller RG (2005) Exercise and training in mitochondrial myopathies. Med Sci Sports Exerc 37:2094-2101
59. Taivassalo T, Fu K, Johns T, Arnold D, Karpati G, Shoubridge EA (1999) Gene shifting: a novel therapy for mitochondrial myopathy. Hum Mol Genet 8:1047-1052
60. Tanaka M, Borgeld HJ, Zhang J, Muramatsu S, Gong JS, Yoneda M, Maruyama W, Naoi M, Ibi T, Sahashi K, Shamoto M, Fuku N, Kurata M, Yamada Y, Nishizawa K, Akao Y, Ohishi N, Miyabayashi S, Umemoto H, Muramatsu T, Furukawa K, Kikuchi A, Nakano I, Ozawa K, Yagi K (2002) Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J Biomed Sci 9:534-541
61. Tarnopolsky MA, Roy BD, MacDonald JR (1997) A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 20:1502-1509
62. Taylor RW, Chinnery PF, Turnbull DM, Lightowlers RN (1997) Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet 15:212-215
63. Tein I, De Vivo DC, Bierman F, Pulver P, De Meirleir LJ, Cvitanovic-Sojat L, Pagon RA, Bertini E, Dionisi-Vici C, Servidei S (1990) Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 28:247-255
64. Tein I, DiMauro S, Xie ZW, De Vivo DC (1993) Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for pathogenesis of valproic acid-associated carnitine deficiency. Pediatr Res 34:281-287